IL-23 and IL-12/23 Inhibitors Show Comparable Safety in Preventing PsA in PsoriasisAugust 16, 2024Psoriatic Arthritis
Bimekizumab Shows Promising Outcomes in PsA, With or Without MethotrexateAugust 16, 2024Psoriatic Arthritis
Rheumatology NewsUS Experience With Infliximab Biosimilars Suggests Need for More Development IncentivesAugust 13, 2024Rheumatoid ArthritisSpondyloarthropathiesPediatricsPsoriatic ArthritisAnkylosing spondylitis
Rheumatology NewsTrends in Rheumatic Disease Pain Management Show Decline in Opioid UseAugust 2, 2024Rheumatoid ArthritisPsoriatic ArthritisLupus & Connective Tissue DiseasesSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsAdvantages of a Pediatric Rheumatology/Dermatology Clinic EvaluatedJuly 30, 2024PediatricsPsoriatic ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsStudy Finds Differences in Side Effect Profiles With Two Oral Psoriasis TherapiesJuly 26, 2024Psoriatic Arthritis
Rheumatology NewsRisk of MACE Comparable Among Biologic Classes for Psoriasis, PsAJuly 26, 2024Psoriatic ArthritisMixed Topics
Rheumatology NewsSteroids’ 75th Anniversary: Clinicians Strive to Use LessJuly 25, 2024Rheumatoid ArthritisPsoriatic ArthritisPediatricsLupus & Connective Tissue Diseases
Rheumatology NewsMysteries Persist About Tissue Resident Memory T Cells in PsoriasisJuly 25, 2024Psoriatic Arthritis
